@article{2997361,
    title = "Olfactory bulb and mucosa abnormalities in persistent COVID-19-induced anosmia: a magnetic resonance imaging study",
    author = "Tsivgoulis, G. and Fragkou, P.C. and Lachanis, S. and Palaiodimou, L. and Lambadiari, V. and Papathanasiou, M. and Sfikakis, P.P. and Voumvourakis, K.I. and Tsiodras, S.",
    journal = "European Journal of Paediatric Neurology",
    year = "2021",
    volume = "28",
    number = "1",
    pages = "e6-e8",
    publisher = "Wiley-Blackwell Publishing Ltd",
    issn = "1090-3798",
    doi = "10.1111/ene.14537",
    keywords = "azithromycin;  corticosteroid;  hydroxychloroquine;  nuclear magnetic resonance imaging agent, adult;  aged;  anosmia;  case control study;  clinical article;  contrast enhancement;  controlled clinical trial;  controlled study;  coronavirus disease 2019;  corticosteroid therapy;  disease severity;  female;  hospital based case control study;  human;  hyposmia;  Letter;  male;  middle aged;  nuclear magnetic resonance imaging;  odor recognition test;  olfactory bulb;  olfactory mucosa;  pilot study;  priority journal;  prospective study;  sino-nasal outcome test-22;  young adult"
}